CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: January 24, 2012
Result type: Reports
Project Number: SR0265
Product Line: Common Drug Review

Generic Name: Plerixafor

Brand Name: Mozobil

Manufacturer: Genzyme Canada Inc.

Indications: Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma

Submission Type: New

Project Status: Complete

Date Recommendation Issued: September 26, 2012

Recommendation Type: Do not list